Jiang, Jin – Trademark Portfolio
Entity Type: 01
Jiang, Jin owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CUKE, TAMIDN, IREBOOT, and JKABTER. Of these, 4 are registered. The portfolio spans 5 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 21 (Housewares). Headquartered in Heilongjiang.
Community, Wudalianchi City
No. 208, Area B, Erlongshan Farmland
Heilongjiang 164100 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiang, Jin's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Machines and machine tools; motors and engines; machine coupling and transmission components
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Jiang, Jin have?
Jiang, Jin has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Jiang, Jin file in?
Jiang, Jin files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 7 (Machinery), Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Jiang, Jin's most well-known trademarks?
Jiang, Jin's registered trademark portfolio includes well-known marks such as CUKE, TAMIDN, IREBOOT, and JKABTER. These are among 4 currently registered trademarks in the portfolio.
What is Jiang, Jin's trademark registration success rate?
Jiang, Jin has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.